Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 8Terminated 2Withdrawn 1Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other solid neoplasm 2Genitourinary 2Gastrointestinal 2CNS 2Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Myelodysplastic Syndromes 9Lymphoma, Non-Hodgkin 7Leukemia 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hematologic Neoplasms 5Congenital Abnormalities 4Breast Neoplasms 4Neuroblastoma 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Wilms Tumor 2Testicular Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Retinoblastoma 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Medulloblastoma 2Liver Neoplasms 2Kidney Neoplasms 2Hepatoblastoma 2Graft vs Host Disease 2Desmoplastic Small Round Cell Tumor 2Central Nervous System Neoplasms 2Astrocytoma 2

Interventions

Filgrastim 4Cyclophosphamide 4Vincristine 3Topotecan 3Melphalan 3Lomustine 3Granulocyte Colony-Stimulating Factor 3Cisplatin 3etoposide phosphate 2Thiotepa 2Temozolomide 2Radiotherapy 2Mesna 2Ifosfamide 2Etoposide 2Carboplatin 2Busulfan 2sonidegib 1sodium thiosulfate 1silmitasertib 1sargramostim 1ribociclib 1poly ICLC 1palbociclib 1omburtamab I-131 1gadobutrol 1gadobenic acid 1bempegaldesleukin 1Yoga 1Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Medulloblastoma × Thiotepa × Clear all
NCT00623077 2017-12-05

MT2004-30: Tomotherapy for Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
23 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma

NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡